Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods—preplanning and intraoperative planning-Reference-Cited by-同舟云学术

Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods—preplanning and intraoperative planning

Published:2003-09 Issue:3 Volume:62 Page:497-502
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Matzkin Haim,Kaver Issac,Stenger Amira,Agai Ruben,Esna Noam,Chen Juza

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Transperineal I-125 seed implantation in prostatic cancer guided by transrectal ultrasonography;Holm;J Urol,1983

2. Ultrasonically guided precise needle placement in the prostate and seminal vesicles;Holm;J Urol,1981

3. Prostate brachytherapy;Stone;J Urol,1999

4. Transperineal ultrasound guided implantation of the prostate;Blasko;Scand J Urol Nephrol Suppl,1991

5. Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer;Grimm;Atlas Urol Clin North Am,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Permanent seed implant brachytherapy in low-risk prostate cancer: Preoperative planning with 145 Gy versus real-time intraoperative planning with 160 Gy;Reports of Practical Oncology & Radiotherapy;2018-07

2. Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis;International braz j urol;2016-10

3. A Case-Based Illustration of Urinary Symptoms Following Radiation Therapy for Prostate Cancer;Urinary Dysfunction in Prostate Cancer;2015-12-09

4. Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer;Journal of Contemporary Brachytherapy;2015

5. Comparison between preoperative and real-time intraoperative planning 125I permanent prostate brachytherapy: long-term clinical biochemical outcome;Radiation Oncology;2013-12